Foresite Capital Management I, LLC

Q1 2014 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
3/31/2014
Date filed
5/15/2014
Form type
13F-HR
Num holdings
11
Total value ($000)
$142,352
Net value change ($000)
+39,412 (38.3%)
New positions
3
Sold out positions
0
Turnover %
12.9%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q4 2013
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
KPTI 16,364 50.2%
OREXIGEN THERAPEUTICS INC 8,125 NEW
BIODELIVERY SCIENCES INTERNATIONAL INC 5,908 NEW
KERYX BIOPHARMACEUTICALS 5,367 31.6%
IGNYTA INC 4,150 NEW
XNCR 2,124 28.3%
TLPH 966 6.2%
Top Reduces (Value $000, Stocks/ETFs)
XLRN -1,893 -72.4%
AMBIT BIOSCIENCES CORP -1,081 -5.4%
NVAX -788 -11.5%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 906 (0.6% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type